Skip to content

Author

Sheeba Irshad

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Abstract C155: Immune profiling reveals distinct ancestry-associated immune surveillance programmes in breast cancer

A large multimodal study integrating clinical, systemic and spatial immune profiling to investigate ethnicity-associated immune surveillance while minimizing socioeconomic confounding demonstrates divergent ancestry-associated alterations in immune surveillance profiles, which likely contributes to mechanisms underpinn...

Bryan Boon Han Ng, Paul R. Buckley, T. Alaguthurai et al. · 0 citations
Sep 2026

Immunodominant Antiviral T Cell Responses Outcompete Antitumor T Cell Responses to Reduce the Efficacy of Oncolytic Viroimmunotherapy.

The paradigm in the field of oncolytic virotherapy proposes that tumor cell killing by an oncolytic virus (OV) culminates in the priming of antitumor CD8+ T cells. However, this ignores the impact a highly immunodominant antiviral response against the OV has on the subdominant antitumor response, particularly regarding...

Benjamin L. Kendall, O. Liseth, T. Sangsuwannukul et al. · 0 citations
Open access Sep 2026

Retrotransposable element derepression distinguishes DNMT3A-mutant from TET2-mutant clonal haematopoiesis.

Results highlight mutation-specific inflammatory mechanisms in clonal haematopoiesis and provide a foundation for future functional and preclinical studies to determine whether modulation of RTE activity can influence the inflammatory phenotype of DNMT3A-mutant CH and represent a potential therapeutic strategy.

Maroof Hasan, Sylvia Durandeau, I. R. Thompson et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.